Oscar Health Inc. <OSCR.N>: Barclays Raises Target Price to $49 From $39
OSCR•Related News
Swiss upper house ends Thursday's debate on UBS rules without voting
UBS•
Accendra Health Names Kenneth Gardner-Smith As President And Chief Executive Officer
ACH•
Americas Gold and Silver reports high-grade Cosalá drilling, including 654.7 g/t silver over 20.5 meters
USAS•
NGL Energy Partners declares Class B preferred distribution of $0.70 per unit
NGL•
Agree Realty Corporation <ADC.N>: Mizuho Cuts Target Price to $72 From $80
ADC•